TheraRadar
← Back
Data updated: Mar 29, 2026

MILLA PHARMS

NeurologyCardiovascularMetabolic
Generics

MILLA PHARMS is a generic drug manufacturer focused on Neurology, Cardiovascular, Metabolic.

2017
Since
9
Drugs
-
Trials
92
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

DEXMEDETOMIDINE HYDROCHLORIDE 2026-02-17
Labeling
TRANEXAMIC ACID 2026-01-26
PYRIDOSTIGMINE BROMIDE 2025-09-26
Labeling
SODIUM ACETATE 2025-09-18
PHENYLEPHRINE HYDROCHLORIDE 2025-09-17
Manufacturing (CMC)
TRANEXAMIC ACID 2025-08-20
Labeling
TRANEXAMIC ACID 2025-08-19
SODIUM ACETATE 2025-08-08
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 50%
2 drugs
Cardiovascular 25%
1 drugs
Metabolic 25%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Novo Nordisk big-pharma
Metabolic, Cardiovascular, Neurology
UPJOHN big-pharma
Neurology, Cardiovascular, Metabolic
AZURITY specialty
Cardiovascular, Neurology, Metabolic
Merck big-pharma
Cardiovascular, Metabolic
Johnson & Johnson big-pharma
Cardiovascular, Metabolic